Riskpilot← Back to searchSign inGet full accessConcordis AB
ABActiveOrg 5591207708Stormviksvägen 130Hospital activities · NACE 8610Est. 20172 employees
Revenue 2025
SEK 313K
-53% vs 2024
EBITDA margin
-149.2%
-4009% vs 2024
Equity ratio
90.7%
Financial strength
Net profit 2025
SEK -480K
-1725% vs 2024
| Revenue | SEK 313K | -53% |
| EBITDA | SEK -467K | -4009% |
| Net profit | SEK -480K | -1725% |
| Total assets | SEK 1,3M | -29% |
| Equity | SEK 1,1M | -30% |
| Employees | 2 | — |
Legal name
Concordis AB
Org number
5591207708
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
1 augusti 2017
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
1. Konsultverksamhet inom hälso- och sjukvård, läkar- och sjuksköterskeuppgifter. 2. Konsultverksamhet inom medicinsk forskning och utbildning 3. Inovation inom medicinsk teknik. 4. Förebyggande hälsovård med föreläsningar, livsstilsförändring och stresshantering i havs- och bergsmiljö.
Address
Stormviksvägen 130
Email
nilswitt@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 625 | 550 | 599 | 667 | 313 |
| Staff expenses | — | −62 | −84 | −39 | −162 |
| EBITDA | 367 | 95 | −8 | −11 | −467 |
| Depreciation & amort. | −5 | −5 | −5 | −12 | −9 |
| EBIT | 362 | 90 | −13 | −23 | −476 |
| Net financials | −3 | −0 | 3 | 3 | −4 |
| Profit before tax | 360 | 90 | −10 | −20 | −480 |
| Tax | −81 | −29 | −12 | −6 | — |
| Net profit | 279 | 61 | −22 | −26 | −480 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 414 | 2 271 | 2 003 | 1 778 | 1 260 |
| Equity | 2 321 | 2 070 | 1 853 | 1 622 | 1 143 |
| Long-term debt | 3 | 16 | 9 | — | 66 |
| Short-term debt | 91 | 185 | 141 | 156 | 51 |
| Total debt | 94 | 201 | 150 | 156 | 117 |
EBITDA margin
-149.2%
This company
15.8%
Market median
-1044% vs market
20212025
Equity ratio
90.7%
This company
38.2%
Market median
+137% vs market
20212025
Return on equity
-42.0%
This company
18.4%
Market median
-328% vs market
20212025
Net profit margin
-153.1%
This company
8.1%
Market median
-1990% vs market
20212025
Asset turnover
0.25×
This company
1.12×
Market median
-78% vs market
20212025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Concordis AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Simon Leonard Torell Witt | Deputy Board Member | 0 companies |
| May Katarina Sjöö | Deputy Board Member | 0 companies |
| Nils Daniel Witt | Board of Directors | 0 companies |